Results 101 to 110 of about 3,066 (203)

Gestational Gigantomastia: A Century of Evidence with a New Case

open access: yesPlastic and Reconstructive Surgery, Global Open
Background:. Gestational gigantomastia (GG) is an extreme, rapidly progressive breast enlargement that can culminate in ulceration, sepsis, cardiopulmonary compromise, and, when care is delayed, maternal death.
Sama K. Fofung, MD, MMed   +3 more
doaj   +1 more source

Additional file 1: of Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation

open access: yes, 2018
Table S1. Sequences of primers for the real time quantitative PCR (qPCR). Figure S1. Postnatal resveratrol treatment increases expression of SOD2 and ERRα, while it has no effect on the expression of ERβ and SIRT1 in the hypothalamus and hippocampus of ...
Yun Jiao (115357)   +15 more
core   +1 more source

Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone/ethinyl estradiol and drospirenone/ethinyl estradiol

open access: yesHeliyon
Background: Deep vein thrombosis (DVT) has been reported as an adverse event for patients receiving combined oral contraceptives. Norethindrone/ethinyl estradiol (NET/EE) and drospirenone/ethinyl estradiol (DRSP/EE) are two commonly prescribed combined ...
Jennifer Stalas   +8 more
doaj   +1 more source

Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery?

open access: yes, 2019
Objective: To compare the effects of Dienogest (D)and Norethindrone acetate (N)in symptomatic women with ovarian endometriomas, analyzing the efficacy in reducing endometrioma size and symptom relief and drug tolerability.
Arena A.   +6 more
core   +1 more source

A Novel Intrauterine Device for the Spatio-Temporal Release of Norethindrone Acetate as a Counter-Estrogenic Intervention in the Genitourinary Syndrome of Menopause

open access: yesPharmaceutics
The genitourinary syndrome of menopause (GSM) is a widely occurring condition affecting millions of women worldwide. The current treatment of GSM involves the use of orally or vaginally administered estrogens, often with the risk of endometrial ...
Ahmed Abdelgader   +3 more
doaj   +1 more source

Comparison of Dermatologic and Neuropsychological Side Effects of Oral Contraceptives, 2016–2020

open access: yesOpen Access Journal of Contraception
Joseph Visingardi,1,* Paul J Feustel,2,* Rachel Flink-Bochacki,3,* Cassandra Denefrio3,* 1Internal Medicine, Albany Medical Center, Albany, NY, USA; 2Neuroscience and Experimental Therapeutics, Albany Medical College ...
Visingardi J   +3 more
doaj  

Genomic and transcriptomic characterization of a novel wastewater-derived Sporosarcina sp. with broad-spectrum bioremediation potential against endocrine disruptors and pharmaceuticals

open access: yesChemical Engineering Journal Advances
Emerging pollutants (EPs) such as pharmaceuticals, hormones, and pesticides are increasingly detected in aquatic environments due to their widespread use and incomplete removal by conventional wastewater treatment plants.
Sumayya Al Ali   +8 more
doaj   +1 more source

Development of efficient SPE–TLC method and evaluation of biological interactions of contraceptives with progesterone receptors

open access: yes, 2012
TLC–SPE methodologies were developed to ascertain biological interactions of norethindrone acetate and dydrogesterone contraceptives with plasma progesterone receptor proteins.
Hussain, Iqbal   +7 more
core   +1 more source

Presurgical treatment of uterine myomas with the GnRH-antagonist relugolix in combination therapy: an observational study

open access: yesScientific Reports
To evaluate if a preoperative medical treatment with the GnRH-antagonist relugolix in combination therapy in a series of patients with abnormal uterine bleeding associated with uterine myomas may correct the anemia before scheduled surgery for myoma ...
Ludovico Muzii   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy